levonorgestrel has been researched along with efavirenz in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (6.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 8 (53.33) | 24.3611 |
| 2020's | 6 (40.00) | 2.80 |
| Authors | Studies |
|---|---|
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Nightingale, SL | 1 |
| Carten, ML; Cu-Uvin, S; Kiser, JJ; Kwara, A; Mawhinney, S | 1 |
| Back, DJ; Buzibye, A; Byakika-Kibwika, P; Cohn, SE; Darin, KM; Dilly Penchala, S; Else, LJ; Lamorde, M; Merry, C; Nakalema, S; Scarsi, KK | 1 |
| Back, DJ; Byakika-Kibwika, P; Darin, KM; Lamorde, M; Merry, C; Neary, M; Olagunju, A; Owen, A; Scarsi, KK; Siccardi, M | 1 |
| Back, DJ; Darin, KM; Fletcher, CV; Lamorde, M; Owen, A; Rajoli, RKR; Roberts, O; Scarsi, KK; Siccardi, M | 1 |
| Chinula, L; Corbett, A; Cottrell, ML; Haddad, LB; Hurst, S; Kourtis, AP; Msika, A; Nelson, JAE; Tang, JH; Wiener, J | 1 |
| Baeten, JM; Blue, SW; Erikson, DW; Kelly, EJ; Kim, CJ; Kourtis, AP; Lingappa, JR; Mugo, N; Nanda, K; Patel, RC; Scarsi, KK; Stalter, RM; Tamraz, B; Thomas, KK | 1 |
| Chaturvedula, A; Cicali, B; Cristofoletti, R; Hoechel, J; Lingineni, K; Schmidt, S; Vozmediano, V; Wendl, T; Wiesinger, H | 1 |
| Amorim, G; Bernard, C; Bukusi, EA; Cohen, CR; Jakait, B; Mocello, AR; Musick, B; Patel, RC; Shepherd, BE; Stalter, RM; Wools-Kaloustian, K; Yiannoutsos, CT | 1 |
| Badal-Faesen, S; Barr, E; Belaunzaran-Zamudio, PF; Cohn, SE; Gadama, L; Gatechompol, S; Godfrey, C; Jalil, EM; Mawlana, S; Mngqibisa, R; Olefsky, M; Pham, M; Podany, AT; Scarsi, KK; Smeaton, LM; Supparatpinyo, K; Woolley, E | 1 |
| Byakika-Kibwika, P; Chappell, CA; Cirrincione, LR; Cohn, SE; Fletcher, CV; Kyohairwe, I; Lamorde, M; Mackline, H; Nakalema, S; Owen, A; Pham, MM; Scarsi, KK; Siccardi, M; Winchester, L | 1 |
| Agyemang, N; Badal-Faesen, S; Baker, P; Barr, E; Belaunzaran-Zamudio, PF; Cohn, SE; Gadama, L; Gatechompol, S; Godfrey, C; Haas, DW; Jalil, EM; Kayama, C; Mawlana, S; Mngqibisa, R; Olefsky, M; Pham, M; Podany, AT; Scarsi, KK; Smeaton, LM; Supparatpinyo, K; Van Schalkwyk, M; Woolley, E | 1 |
| Chinula, L; Corbett, AH; Cottrell, ML; Gajer, P; Haddad, LB; Hurst, S; Kourtis, AP; Lantz, AM; Nelson, JAE; Nicol, MR; Ravel, J; Tang, JH; Tegha, G | 1 |
1 review(s) available for levonorgestrel and efavirenz
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
5 trial(s) available for levonorgestrel and efavirenz
| Article | Year |
|---|---|
Unintended Pregnancies Observed With Combined Use of the Levonorgestrel Contraceptive Implant and Efavirenz-based Antiretroviral Therapy: A Three-Arm Pharmacokinetic Evaluation Over 48 Weeks.
Topics: Adolescent; Adult; Alkynes; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Benzoxazines; Contraceptive Agents, Female; Cyclopropanes; Drug Interactions; Female; HIV Infections; HIV-1; Humans; Levonorgestrel; Nevirapine; Pregnancy; Pregnancy, Unplanned; Reverse Transcriptase Inhibitors; Time Factors; Uganda | 2016 |
The Effect of Gene Variants on Levonorgestrel Pharmacokinetics When Combined With Antiretroviral Therapy Containing Efavirenz or Nevirapine.
Topics: Adult; Alkynes; Area Under Curve; Benzoxazines; Constitutive Androstane Receptor; Contraceptive Agents, Female; Cyclopropanes; Cytochrome P-450 CYP2A6; Cytochrome P-450 CYP2B6; Female; Genetic Variation; HIV Infections; Humans; Levonorgestrel; Linear Models; Multivariate Analysis; Nevirapine; Pharmacogenetics; Polymorphism, Single Nucleotide; Prospective Studies; Reverse Transcriptase Inhibitors | 2017 |
Brief Report: HIV Shedding in the Female Genital Tract of Women on ART and Progestin Contraception: Extended Follow-up Results of a Randomized Clinical Trial.
Topics: Adult; Alkynes; Anti-Retroviral Agents; Benzoxazines; Cervix Uteri; Contraception; Contraceptive Agents, Female; Cyclopropanes; Drug Implants; Female; Follow-Up Studies; Genitalia, Female; HIV Infections; Humans; Levonorgestrel; Malawi; Medroxyprogesterone Acetate; Progestins; Treatment Outcome; Virus Shedding | 2019 |
Pharmacokinetics of dose-adjusted levonorgestrel emergency contraception combined with efavirenz-based antiretroviral therapy or rifampicin-containing tuberculosis regimens.
Topics: Adolescent; Benzoxazines; Contraception, Postcoital; Female; HIV Infections; Humans; Levonorgestrel; Rifampin; Tuberculosis | 2023 |
Effect of double-dose levonorgestrel subdermal implant in women taking efavirenz-based antiretroviral therapy: The DoubLNG pharmacokinetic study.
Topics: Adolescent; Adult; Benzoxazines; Contraceptive Agents, Female; Female; HIV Infections; Humans; Levonorgestrel; Middle Aged; Pregnancy; Young Adult | 2023 |
9 other study(ies) available for levonorgestrel and efavirenz
| Article | Year |
|---|---|
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
From the Food and Drug Administration.
Topics: Alkynes; Anti-HIV Agents; Benzoxazines; Contraceptives, Postcoital; Cyclopropanes; Drug Approval; Ethinyl Estradiol; Humans; Levonorgestrel; Oxazines; Reverse Transcriptase Inhibitors; United States; United States Food and Drug Administration | 1998 |
Pharmacokinetic interactions between the hormonal emergency contraception, levonorgestrel (Plan B), and Efavirenz.
Topics: Adult; Alkynes; Anti-HIV Agents; Area Under Curve; Benzoxazines; Contraceptive Agents, Female; Cyclopropanes; Drug Interactions; Drug Therapy, Combination; Female; Humans; Levonorgestrel; Middle Aged; Prospective Studies; Therapeutic Equivalency; Young Adult | 2012 |
Physiologically based pharmacokinetic modelling prediction of the effects of dose adjustment in drug-drug interactions between levonorgestrel contraceptive implants and efavirenz-based ART.
Topics: Adolescent; Adult; Alkynes; Antiretroviral Therapy, Highly Active; Benzoxazines; Contraceptive Agents, Female; Cyclopropanes; Drug Interactions; Female; Humans; Levonorgestrel; Middle Aged; Models, Statistical; Plasma; Reverse Transcriptase Inhibitors; Young Adult | 2018 |
A pharmacokinetic and pharmacogenetic evaluation of contraceptive implants and antiretroviral therapy among women in Kenya and Uganda.
Topics: Adult; Alkynes; Anti-HIV Agents; Benzoxazines; Contraceptive Agents, Female; Cyclopropanes; Desogestrel; Drug Antagonism; Female; HIV Infections; Humans; Kenya; Levonorgestrel; Linear Models; Nevirapine; Pharmacogenomic Testing; Uganda | 2019 |
Quantitative Assessment of Levonorgestrel Binding Partner Interplay and Drug-Drug Interactions Using Physiologically Based Pharmacokinetic Modeling.
Topics: Adult; Alkynes; Benzoxazines; Body Mass Index; Carbamazepine; Clarithromycin; Computer Simulation; Contraceptives, Oral, Combined; Cyclopropanes; Cytochrome P-450 CYP3A Inducers; Cytochrome P-450 CYP3A Inhibitors; Drug Combinations; Drug Interactions; Ethinyl Estradiol; Female; Humans; Itraconazole; Levonorgestrel; Models, Biological; Obesity; Rifampin; Sex Hormone-Binding Globulin | 2021 |
Contraceptive implant use duration is not associated with breakthrough pregnancy among women living with HIV and using efavirenz: a retrospective, longitudinal analysis.
Topics: Adolescent; Adult; Alkynes; Benzoxazines; Contraceptive Agents; Cyclopropanes; Female; HIV Infections; Humans; Levonorgestrel; Middle Aged; Nevirapine; Pregnancy; Retrospective Studies; Young Adult | 2022 |
Pharmacogenetic interactions of efavirenz or rifampin and isoniazid with levonorgestrel emergency contraception during treatment of HIV or tuberculosis.
Topics: Anti-HIV Agents; Antitubercular Agents; Benzoxazines; Contraception, Postcoital; Cytochrome P-450 CYP2B6; Cytochrome P-450 CYP3A; Female; Genotype; HIV Infections; Humans; Isoniazid; Levonorgestrel; Pharmacogenetics; Rifampin; Tuberculosis | 2023 |
Vaginal microbiome, antiretroviral concentrations, and HIV genital shedding in the setting of hormonal contraception initiation in Malawi.
Topics: Anti-Retroviral Agents; Female; HIV Infections; Hormonal Contraception; Humans; Lamivudine; Levonorgestrel; Malawi; Medroxyprogesterone Acetate; Microbiota; Tenofovir; Vagina | 2023 |